Myriad Genetics Inc (MYGN)

R&D Expenses

$25.00M

Quarterly · Period ending: · USD

MYGN logo

MYGN R&D Expenses

Latest reported$25.00M
MYGN Quarterly R&D Expenses ($0.00 → $25.00M)
High-resolution chart · PNG

MYGN r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
7,247,908
8,428,402
9,351,036
8,790,797
7,773,769
8,333,000
6,200,000
5,800,000
5,900,000
6,100,000
5,700,000
5,800,000
6,300,000
5,500,000
5,000,000
6,200,000
5,200,000
4,200,000
5,000,000
4,100,000
4,200,000
3,700,000
2,800,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.